ResMed | RMD - Current Assets

Stock Price
230.84
Daily Change
-1.57 -0.68%
Monthly
-9.76%
Yearly
2.98%
Q1 Forecast
223.87

ResMed reported $3.82B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Ansell USD 1.11B 5.2M Dec/2025
Artivion USD 337.5M 18.68M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Cochlear AUD 1.37B 43.9M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Fisher Paykel Healthcare NZD 983.7M 48.3M Dec/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Idexx Laboratories USD 1.41B 63.23M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24B 773M Sep/2025
Philips EUR 9.93B 654M Dec/2025
Ramsay Health Care AUD 3.56B 480.3M Dec/2025
ResMed USD 3.82B 193.06M Dec/2025
Sigma Healthcare AUD 2.91B 2B Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Steris USD 2.29B 179.9M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025